2.32 USD
↗ 0.01 (0.22%)LIVE (AS OF 09:37 AM EDT)
Lexicon Pharmaceuticals, Inc.
LXRXNASDAQ • USD
Market: OPEN
Lexicon Pharmaceuticals, Inc. (LXRX) trades at $2.32 per share. Technicals currently rate "Neutral" while our fundamental analysis reads "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Aug 26, 2026.
Open?$2.31
High?$2.36
Low?$2.30
Prev. Close?$2.31
Volume?40.1K
Avg. Volume?2.8M
VWAP?$2.31
Rel. Volume?0.01x
Bid / Ask
Bid?$1.92 × 100
Ask?$2.67 × 100
Spread?$0.75
Midpoint?$2.30
Valuation & Ratios
Market Cap?1.0B
Shares Out?445.0M
Float?226.4M
Float %?50.9%
P/E Ratio?N/A
P/B Ratio?5.89
EPS?-$0.14
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
Employees
81
Market Cap
1.0B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2000-04-07
Address
2445 TECHNOLOGY FOREST BLVD.
THE WOODLANDS, TX 77381
Phone: (281) 863-3000
THE WOODLANDS, TX 77381
Phone: (281) 863-3000
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?0
Momentum?10
Short Sent.?28
Piotroski F-Score?2/9Weak
Altman Z-Score?-3.02Distress
Confidence?71%Moderate
Short InterestVery High
Short % of Float?14.46%High
Short Interest?32.7M
Days to Cover?10.9
Free Float226.4M
Avg Daily Volume3.0M
Settlement Date2026-08-14
Financial Health
Current Ratio?13.37Strong
Quick Ratio?13.29Strong
Cash Ratio?2.78Strong
Debt/Equity?0.29Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?5.89FAIR▾
Peers100
S&P31
P/S?24.88HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-18.6CHEAP▾
S&P97
EV/Sales?25.13HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-35.0%WEAK▾
S&P5
ROA?-24.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-64988000
Enterprise Value?$1.0B
Fundamentals ratios updated end of day